Home

vonalzó özön legénység mateon therapeutics megközelítés válás Polgárság

EX-4.1
EX-4.1

Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate,  Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs

Articles about Mateon Therapeutics, Inc.
Articles about Mateon Therapeutics, Inc.

NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts |  Justia
NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia

Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement  PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science &  Technology
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology

Corporate Videos – Oncotelic
Corporate Videos – Oncotelic

Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy  platform - Express Pharma
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma

Mateon Therapeutics completes acquisition of PointR Data
Mateon Therapeutics completes acquisition of PointR Data

Mateon Therapeutics Announces Termination of FOCUS Study in
Mateon Therapeutics Announces Termination of FOCUS Study in

MATEON THERAPEUTICS AKTIE | Aktienkurs | US6283411097 | News | A14Y0U |  finanzen.net
MATEON THERAPEUTICS AKTIE | Aktienkurs | US6283411097 | News | A14Y0U | finanzen.net

Windlas Biotech, Mateon Therapeutics launch integrated solution for  respiratory wellness in India
Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India

Mateon Therapeutics Company Profile: Valuation, Investors, Acquisition |  PitchBook
Mateon Therapeutics Company Profile: Valuation, Investors, Acquisition | PitchBook

Zacks Small-Cap Research
Zacks Small-Cap Research

A Covid-19 treatment plan slowly emerges | Evaluate
A Covid-19 treatment plan slowly emerges | Evaluate

Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic  Engineering & Biotechnology News - EmergingGrowth.com
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com

FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.

MATN: Positive Early Results for ARTIVeda™ in Treating COVID-19…
MATN: Positive Early Results for ARTIVeda™ in Treating COVID-19…

About Us – Oncotelic
About Us – Oncotelic

Consulting Agreement by and between the Company and Artius, | MATEON  THERAPEUTICS INC | Business Contracts | Justia
Consulting Agreement by and between the Company and Artius, | MATEON THERAPEUTICS INC | Business Contracts | Justia

Mateon and PointR to merge into AI-driven oncology firm
Mateon and PointR to merge into AI-driven oncology firm

Mateon Therapeutics (MATN) expands its management team to accelerate the  commercialization and development of OT-101 for COVID-19 -  EmergingGrowth.com
Mateon Therapeutics (MATN) expands its management team to accelerate the commercialization and development of OT-101 for COVID-19 - EmergingGrowth.com

Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON  THERAPEUTICS INC | Business Contracts | Justia
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia

Windlas Biotech and Mateon Therapeutics Launch India's First Combined Lung  Therapy and Ai Telemedicine 360 Solution to Transform Respiratory Wellness  - The Pharma Times | Pharma & Health Care News Portal
Windlas Biotech and Mateon Therapeutics Launch India's First Combined Lung Therapy and Ai Telemedicine 360 Solution to Transform Respiratory Wellness - The Pharma Times | Pharma & Health Care News Portal

EDGAR Filing Documents for 0001493152-21-001207
EDGAR Filing Documents for 0001493152-21-001207

Mateon Therapeutics
Mateon Therapeutics

Mateon Therapeutics - BIO Investor Forum | BIO
Mateon Therapeutics - BIO Investor Forum | BIO

Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit

Mateon Therapeutics Archives - IndiaMedToday
Mateon Therapeutics Archives - IndiaMedToday

Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung  Therapy Combined AI 360 platform for respiratory wellness - The Statesman
Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness - The Statesman

MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST